{
  "id": 18093309,
  "title": "Novo Nordisk’s Wegovy pill beats forecasts as it battles Lilly",
  "url": "https://urgent.news/2026/11/04/novo-nordisks-wegovy-pill-beats-forecasts-as-it-battles-lilly",
  "topic": "world",
  "section": "World",
  "published": "2026-11-04T07:43:47.000Z",
  "source": {
    "name": "Free Malaysia Today",
    "slug": "free-malaysia-today",
    "url": "https://www.freemalaysiatoday.com/category/business/2026/11/04/novo-nordisk-s-wegovy-pill-beats-forecasts-as-it-battles-lilly"
  },
  "original_language": "en",
  "account": null,
  "summary": "Sales of Novo Nordisk's Wegovy pill were kr5.39 billion, up 53% from Q2 and above the kr4.62 billion forecast in the company-compiled consensus.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}